InvestorsHub Logo
icon url

DonShimoda

05/05/11 10:23 AM

#7668 RE: biotech_researcher #7667

The risk is in the FDA approval...


Meeting the primary endpoint along with the lack of alternative treatment options mitigates this risk to a large degree.